# Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer

> **NCT05129046** · — · UNKNOWN · sponsor: **Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05129046
- **Lead sponsor:** Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2024-04-15
- **Final completion:** 2025-11-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129046, "Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05129046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*